GlycoNex Incorporation (4168.TWO)
TWD 26.0
(1.36%)
TWD 26.0
(1.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -183.92 Million | -167.54 Million | -140.86 Million | -145.59 Million | - |
| Net Income | -163.71 Million | -219.82 Million | -172.49 Million | -161.41 Million | - |
| Depreciation & Amortization | 31.17 Million | 39.95 Million | 40.13 Million | 46.58 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | 3.34 Million | -2.82 Million | 11.17 Million | - |
| Change in working capital | 19.04 Million | 6.24 Million | -5.79 Million | -12.15 Million | - |
| Other non-cash items | -3.65 Million | -232 Thousand | -2.73 Million | -624 Thousand | - |
| Investing Cash Flow | 257.92 Million | -399.57 Million | 113.21 Million | -199.68 Million | - |
| Investments in PPE | -23.42 Million | -8.68 Million | -6.83 Million | -1.87 Million | - |
| Acquisitions | 237.46 Million | - | - | - | - |
| Investment purchases | - | -390.05 Million | 119.69 Million | -274.51 Million | - |
| Sales/Maturities of investments | 46.27 Million | - | 617 Thousand | 11.23 Million | - |
| Other Investing Activities | -2.39 Million | -829 Thousand | -253 Thousand | - | -236 Thousand |
| Financing Cash Flow | -6.72 Million | 524.24 Million | -27 Thousand | 379.27 Million | - |
| Debt repayment | -5 Million | -421.45 Million | - | -295.88 Million | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 102.5 Million | - | 84.53 Million | - |
| Other Financing Activities | -1.72 Million | 287 Thousand | -27 Thousand | -1.14 Million | - |
| Accounts receivables | -769 Thousand | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | 19.81 Million | - | - | - | - |
| Cash at beginning of period | 82.18 Million | 125.06 Million | 152.74 Million | 118.74 Million | - |
| Cash at end of period | 149.46 Million | 82.18 Million | 125.06 Million | 152.74 Million | - |
| Capital Expenditure | -23.42 Million | -8.68 Million | -6.83 Million | -1.87 Million | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 67.28 Million | -42.88 Million | -27.67 Million | 33.99 Million | - |
| Free Cash Flow | -207.34 Million | -176.23 Million | -147.7 Million | -147.46 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -49.99 Million | -72.7 Million | -163.71 Million | -63.69 Million | -60.09 Million | 18.47 Million |
| Depreciation & Amortization | 8.52 Million | 7.65 Million | 31.17 Million | 7.43 Million | 7.5 Million | 7.55 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -28.66 Million | 14.84 Million | 19.04 Million | 30.57 Million | -13.26 Million | 11.49 Million |
| Other non-cash items | -772 Thousand | -976 Thousand | -3.65 Million | -1.37 Million | -1.37 Million | -574 Thousand |
| Investing Cash Flow | 52.89 Million | 48.74 Million | 257.92 Million | 64.41 Million | -153.16 Million | 292.06 Million |
| Investments in PPE | -12.78 Million | -10.44 Million | -23.42 Million | -12.19 Million | -5.79 Million | -3.04 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | 59.7 Million | - | 30.38 Million | -30.38 Million | -57.39 Million |
| Sales/Maturities of investments | 65 Million | - | 46.27 Million | - | - | - |
| Other Investing Activities | 671 Thousand | -522 Thousand | -2.39 Million | -53 Thousand | -1.15 Million | -799 Thousand |
| Financing Cash Flow | -287 Thousand | - | -6.72 Million | - | -1.79 Million | -9.93 Million |
| Debt repayment | -1.41 Million | - | -5 Million | - | - | -10 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -287 Thousand | - | -1.72 Million | - | -1.79 Million | 65 Thousand |
| Accounts receivables | -20 Thousand | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 21.15 Million | - | - | - | - | - |
| Cash at beginning of period | 148.95 Million | 149.46 Million | 82.18 Million | 109.84 Million | 330.07 Million | 83.2 Million |
| Cash at end of period | 117.96 Million | 148.95 Million | 149.46 Million | 149.46 Million | 109.84 Million | 330.07 Million |
| Capital Expenditure | -12.78 Million | -10.44 Million | -23.42 Million | -12.19 Million | -5.79 Million | -3.04 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -30.99 Million | -516 Thousand | 67.28 Million | 39.62 Million | -220.22 Million | 246.86 Million |
| Free Cash Flow | -96.37 Million | -59.7 Million | -207.34 Million | -36.98 Million | -71.05 Million | -38.3 Million |
3646
0871
0QO8
TEGY
PSPN
002995